WallStSmart
MAIA

MAIA Biotechnology Inc.

AMEX: MAIA · HEALTHCARE · BIOTECHNOLOGY

$1.32
-9.33% today

Updated 2026-06-05

Market cap
$82.69M
P/E ratio
P/S ratio
EPS (TTM)
$-0.68
Dividend yield
52W range
$1 – $3
Volume
0.8M

WallStSmart proprietary scores

20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.5
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$12.13
+818.94%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-5.31M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-15.77M$-19.77M$-23.25M$-22.40M$-6.37M
EPS$-0.68
Free cash flow$-12.10M$-13.07M$-15.70M$-18.84M$-5.31M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
MAIA$82.69M204.33.05.05.5Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

MAIA Biotechnology Inc. trades at $1.32. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is MAIA Biotechnology Inc.'s stock price?

MAIA Biotechnology Inc. (MAIA) trades at $1.32.

Is MAIA Biotechnology Inc. overvalued?

MAIA Biotechnology Inc. carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of MAIA Biotechnology Inc. (MAIA)?

The 12-month analyst consensus target is $12.13, about 818.9% above the current $1.32. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeAMEX
CurrencyUSD

Quick metrics

P/S ratio
ROE-87.34%
Beta0.24
50D MA$1.32
200D MA$1.51
Shares out0.06B
Float0.05B
Short ratio
Avg volume0.8M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years